Can AI Help Doctors Find Cancer Faster?

Life Sciences 360

Content provided by Harsh Thakkar. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Harsh Thakkar or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

2M ago 36:55

MP3•Episode home

Have you ever wondered if AI could help doctors find cancer faster and more accurately? In this episode, we explore OmniScreen, an AI-powered biomarker tool that is revolutionizing cancer diagnostics.

Joe Oakley, a pathologist and expert in digital pathology, explains how OmniScreen was trained on 3 million digital slides to detect cancer biomarkers with higher precision and speed. He shares how AI is reducing testing time, preserving tissue samples, and improving early cancer detection.

We also tackle the big question: Will AI replace pathologists? Joe breaks down the role of AI in pathology and why it should be seen as a tool to assist rather than replace doctors. Plus, learn how AI is helping hospitals, pharmaceutical companies, and researchers in drug development and clinical trials.

🔹 Key Topics Covered:
✔️ How OmniScreen is transforming cancer diagnostics
✔️ AI vs. traditional cancer detection methods
✔️ The role of AI in hospitals, pharma, and research
✔️ Will AI replace pathologists? The expert’s take
✔️ The future of AI-driven cancer research

🎙️ Guest: Joe Oakley, Lead Consultant/ Founder at Oakley Pathology Consultants, LLC
🔗 Connect with Joe Oakley: LinkedIn

📌 Chapters:
00:00 Introduction
00:49 The problem: Can AI find cancer faster?
01:19 How OmniScreen speeds up cancer detection
01:58 The AI behind OmniScreen: Trained on 3 million slides
02:28 How cancer diagnosis worked before AI
04:31 The evolution of pathology and diagnostic tools
06:10 Why AI can detect cancer better than traditional tests
07:24 How OmniScreen works step by step
08:34 The real impact: Saving time, tissue, and costs
10:04 Who are the early adopters of OmniScreen?
11:59 The role of hospitals, pharma, and researchers
14:12 The cost of AI-driven cancer detection
15:52 The big debate: Will AI replace pathologists?
17:10 Why AI is a tool, not a replacement
19:35 Future impact on drug development and clinical trials
22:09 AI’s role in personalized medicine
24:42 The future of AI in cancer research
27:10 How AI is changing clinical trials
30:05 Key takeaways from the episode
32:40 Where to find Joe Oakley & final thoughts
36:00 Closing remarks

Subscribe for more insights on AI and healthcare!

For transcripts, check out the podcast website - www.lifesciencespod.com

Chapters

1. Introduction (00:00:00)

2. The problem: Can AI find cancer faster? (00:00:49)

3. How OmniScreen speeds up cancer detection (00:01:19)

4. The AI behind OmniScreen: Trained on 3 million slides (00:01:58)

5. How cancer diagnosis worked before AI (00:02:28)

6. The evolution of pathology and diagnostic tools (00:04:31)

7. Why AI can detect cancer better than traditional tests (00:06:10)

8. How OmniScreen works step by step (00:07:24)

9. The real impact: Saving time, tissue, and costs (00:08:34)

10. Who are the early adopters of OmniScreen? (00:10:04)

11. The role of hospitals, pharma, and researchers (00:11:59)

12. The cost of AI-driven cancer detection (00:14:12)

13. The big debate: Will AI replace pathologists? (00:15:52)

14. Why AI is a tool, not a replacement (00:17:10)

15. Future impact on drug development and clinical trials (00:19:35)

16. AI’s role in personalized medicine (00:22:09)

17. The future of AI in cancer research (00:24:42)

18. How AI is changing clinical trials (00:27:10)

19. Key takeaways from the episode (00:30:05)

20. Where to find Joe Oakley & final thoughts (00:32:40)

21. Closing remarks (00:36:00)

82 episodes

#Science #Biology #Harsh Thakkar #Life Sciences #Quality Management #Regulatory Compliance #Biotechnology #Pharmaceutical #Medical Device #Med Tech